Another limitation is the existence of genetic variations in certain genes involved in lipoprotein metabolism that could be related to atherogenesis, such as the FTO gene, which is associated with obesity, insulin resistance, and BMI changes, respectively [69]. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.